Bryan Larsen Selected Research

Vaginitis

12/2021	Antimicrobial Activity of a Vaginal Gel Formulation: Considerations Related to Vaginal Infection and Dysbiosis.
2/2009	Antifungal mechanisms supporting boric acid therapy of Candida vaginitis.
1/2008	Tetracycline effects on Candida albicans virulence factors.
1/2003	Relationship of fungal vaginitis therapy to prior antibiotic exposure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bryan Larsen Research Topics

Disease

4	Vaginitis 12/2021 - 01/2003
2	Infections 12/2021 - 02/2009
2	Vulvovaginal Candidiasis 01/2008 - 01/2003
1	Urinary Tract Infections (Urinary Tract Infection) 02/2022
1	Dysbiosis 12/2021
1	Cumulative Trauma Disorders (Repetitive Strain Injury) 08/2020
1	Premature Birth (Birth, Premature) 01/2011
1	Premature Obstetric Labor (Premature Labor) 01/2010
1	Vulvovaginitis 01/2003

Drug/Important Bio-Agent (IBA)

2	Anti-Bacterial Agents (Antibiotics)IBA 02/2022 - 01/2003
2	CytokinesIBA 08/2020 - 01/2010
1	Excipients (Suspending Agents)IBA 12/2021
1	Vaginal Creams, Foams, and Jellies (Vaginal Tablet)IBA 12/2021
1	Progesterone FDA LinkGeneric 01/2011
1	boric acid (boron oxide hydroxide)IBA 02/2009
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2008

Therapy/Procedure

2	Therapeutics 02/2009 - 01/2003